Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Eu Yan Sang, a TCM Maker/Retailer, Receives $196 Million Buyout Offer

publication date: May 16, 2016
Eu Yan Sang International, a TCM company that is headquartered and listed in Singapore, received a $196 million privatization offer. The offer was made by the founding Eu family, Tower Capital and Temasek Holdings, Singapore's sovereign wealth fund. Eu Yan Sang operates over 300 retail outlets in Hong Kong, Macau, China, Malaysia, Singapore and Australia. It also has two factories in Hong Kong and Malaysia as well as 27 TCM clinics in Malaysia and Singapore, plus two integrative medical centers in Hong Kong. More details....

Stock Symbol: (SGX: E02)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital